BKKT Investors Have Opportunity to Lead Bakkt Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Stock Information for Actinium Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Actinium Pharmaceuticals Inc.

Bakkt Files Post-Effective Amendments to Form S-3 Registration Statements Following Corporate Reorganization
Bakkt Reports Third Quarter 2025 Results
Clear Street's Disruptive Technology Conference Convenes this Month in Palm Beach
Bakkt Completes Capital Structure Simplification and Single-Class Stock Transition
Bakkt and ICE Strengthen Long-Term Alignment Through Board Transition
Bakkt Schedules Conference Call to Discuss Third Quarter 2025 Results
Bakkt Strengthens Board with Appointment of Renowned Macro Strategist Lyn Alden
Bakkt Announces Plan to Simplify Capital Structure and Transition to a Single-Class Common Stock

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.